Vir Biotechnology Inc logo

Vir Biotechnology Inc

2
2
NAS:VIR (USA)  
$ 8.96 -0.27 (-2.92%) 10:08 PM EST
At Loss
P/B:
0.78
Enterprise V:
$ -148.82M
Volume:
527.60K
Avg Vol (2M):
1.06M
Also Trade In:
Volume:
527.60K
At Loss
Avg Vol (2M):
1.06M

Business Description

Description
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Name Current Vs Industry Vs History
Cash-To-Debt 12.22
Equity-to-Asset 0.83
Debt-to-Equity 0.08
Debt-to-EBITDA -0.19
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.93
Distress
Grey
Safe
Beneish M-Score -9.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 24.52
9-Day RSI 28.2
14-Day RSI 33.36
6-1 Month Momentum % 28.81
12-1 Month Momentum % -54.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.05
Quick Ratio 9.05
Cash Ratio 8.68
Days Payable 1079.66

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.9
Shareholder Yield % 0.36

Financials (Next Earnings Date:2024-05-03 Est.)

VIR's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VIR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vir Biotechnology Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 39.494
EPS (TTM) ($) -4.59
Beta 1.69
Volatility % 63.1
14-Day RSI 33.36
14-Day ATR ($) 0.435938
20-Day SMA ($) 9.8295
12-1 Month Momentum % -54.71
52-Week Range ($) 7.72 - 27.48
Shares Outstanding (Mil) 135.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vir Biotechnology Inc Filings

Filing Date Document Date Form
No Filing Data

Vir Biotechnology Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Vir Biotechnology Inc Frequently Asked Questions

What is Vir Biotechnology Inc(VIR)'s stock price today?
The current price of VIR is $8.96. The 52 week high of VIR is $27.48 and 52 week low is $7.72.
When is next earnings date of Vir Biotechnology Inc(VIR)?
The next earnings date of Vir Biotechnology Inc(VIR) is 2024-05-03 Est..
Does Vir Biotechnology Inc(VIR) pay dividends? If so, how much?
Vir Biotechnology Inc(VIR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1